Literature DB >> 12206984

[Brachial fluoroscopically guided implantation of venous port devices in oncology patients].

Pierre-Yves Marcy1, Nicolas Magné, Cédric Bailet, Jean-Claude Gallard, Bruno Valenza, Maurice Schneider, François Demard, Franck Bentolila.   

Abstract

Access to the central venous circulation for chemotherapy infusion has traditionally been achieved surgically via the subclavian or jugular routes. With ongoing improvements in technical management, alternative means of central venous access have been developed such as arm-port or forearm-port implantation under imaging guidance. Venous arm port devices implantation was attempted in 200 cancer patients under fluoroscopic guidance, after arm venography. The 4% failure rate was due to the inability to perform the arm venogram, venous spasm or presence of a large contrast medium hematoma (rolling vein). Median follow-up was 180 days (range 4-671) and the complication rate was 13.3% (0.7/1,000 patients-day). Twenty-six complications occurred and were due to venous thrombosis (n = 3), large brachial hematoma (n = 1), local (n = 7) and systemic sepsis (n = 1), skin dehiscence (n = 4), fissuration (n = 4), dislocation (n = 2), obstruction (n = 2), and twist of the port (n = 2), leading to a 8.5% removal rate. Main indications for arm port implantation may be breast cancer, previous arm or cervical venous thrombosis, morbid obesity, respiratory insufficiency, previous surgical failure and the irradiated neck.

Entities:  

Mesh:

Year:  2002        PMID: 12206984

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  2 in total

1.  Upper-Extremity Deep Vein Thrombosis in Patients With Breast Cancer With Chest Versus Arm Central Venous Port Catheters.

Authors:  Danielle Tippit; Eric Siegel; Daniella Ochoa; Angela Pennisi; Erica Hill; Amelia Merrill; Mark Rowe; Ronda Henry-Tillman; Aneesha Ananthula; Issam Makhoul
Journal:  Breast Cancer (Auckl)       Date:  2018-04-20

2.  Experience in totally implantable venous port catheter: Analysis of 3,000 patients in 12 years.

Authors:  Fazlı Yanık; Yekta Altemur Karamustafaoğlu; Adem Karataş; Yener Yörük
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-07-03       Impact factor: 0.332

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.